Trademark: 88071814
Status Date
Tuesday, April 6, 2021
Registration Number
6316056
Registration Date
Tuesday, April 6, 2021
Filing Date
Thursday, August 9, 2018
Published for Opposition
Tuesday, June 9, 2020
9 Laboratory apparatus for testing of plasma, serum, sputum, fecal, and urine samples for research purposes; all of the foregoing for use in connection with a fluorescence multi-analyte immunoassay system for laboratory research use and not for use in connection with detecting nucleic acid
5 Pharmaceutical and veterinary products, namely, fluorescence multi-analyte immunoassay system for medical diagnostic use, namely, gastrointestinal, neurological, autoimmune, infectious, hepatological, rheumatologic, nephrological, dermatological, coagulation, endocrine, pulmonologic, immune system related, and respiratory diseases; clinical diagnostic assays for medical purposes, namely, identifying and diagnosing of gastrointestinal, neurological, autoimmune, infectious, hepatological, rheumatologic, nephrological, dermatological, coagulation, endocrine, pulmonologic, immune system related, and respiratory diseases; all of the foregoing for use in connection with a fluorescence multi-analyte immunoassay system for medical diagnostic use and not for use in connection with detecting nucleic acid
1 Chemical products for scientific purposes, namely, biomarkers for scientific testing; reagents for scientific and research use; all of the foregoing for use in connection with a fluorescence multi-analyte immunoassay system for medical research use and not for use in connection with detecting nucleic acid
10 Apparatus and instruments for medical diagnosis, namely, medical apparatus for diagnosing, monitoring, and treating gastrointestinal, neurological, autoimmune, infectious, hepatological, rheumatologic, nephrological, dermatological, coagulation, endocrine, pulmonologic, immune system related, and respiratory diseases; all of the foregoing for use in connection with a fluorescence multi-analyte immunoassay system for medical diagnostic use and not for use in connection with detecting nucleic acid
Jul 22, 2022
Teas Change Of Correspondence Received
Jul 22, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Jul 22, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Apr 6, 2021
Registered-Principal Register
Feb 27, 2021
Notice Of Acceptance Of Statement Of Use E-Mailed
Feb 26, 2021
Allowed Principal Register - Sou Accepted
Feb 13, 2021
Notice Of Approval Of Extension Request E-Mailed
Feb 12, 2021
Statement Of Use Processing Complete
Jan 29, 2021
Use Amendment Filed
Feb 12, 2021
Sou Extension 1 Granted
Jan 29, 2021
Sou Extension 1 Filed
Feb 12, 2021
Case Assigned To Intent To Use Paralegal
Jan 29, 2021
Teas Extension Received
Jan 29, 2021
Teas Statement Of Use Received
Aug 4, 2020
Noa E-Mailed - Sou Required From Applicant
Jun 9, 2020
Official Gazette Publication Confirmation E-Mailed
Jun 9, 2020
Published For Opposition
May 20, 2020
Notification Of Notice Of Publication E-Mailed
May 4, 2020
Electronic Record Review Complete
May 1, 2020
On Hold - Electronic Record Review Required
Apr 29, 2020
Exparte Appeal Terminated
Apr 29, 2020
Approved For Pub - Principal Register
Apr 28, 2020
Assigned To Lie
Apr 24, 2020
Teas Request For Reconsideration Received
Apr 24, 2020
Ex Parte Appeal-Instituted
Apr 24, 2020
Jurisdiction Restored To Examining Attorney
Apr 24, 2020
Exparte Appeal Received At Ttab
Apr 14, 2020
Notification Of Final Refusal Emailed
Apr 14, 2020
Final Refusal E-Mailed
Apr 14, 2020
Final Refusal Written
Mar 11, 2020
Teas/Email Correspondence Entered
Mar 11, 2020
Correspondence Received In Law Office
Mar 11, 2020
Teas Response To Suspension Inquiry Received
Jan 25, 2020
Notification Of Inquiry As To Suspension E-Mailed
Jan 25, 2020
Inquiry To Suspension E-Mailed
Jan 25, 2020
Suspension Inquiry Written
Jul 2, 2019
Notification Of Letter Of Suspension E-Mailed
Jul 2, 2019
Letter Of Suspension E-Mailed
Jul 2, 2019
Suspension Letter Written
Jun 11, 2019
Teas/Email Correspondence Entered
Jun 11, 2019
Correspondence Received In Law Office
Jun 11, 2019
Assigned To Lie
Jun 6, 2019
Teas Response To Suspension Inquiry Received
Jun 5, 2019
Notification Of Letter Of Suspension E-Mailed
Jun 5, 2019
Letter Of Suspension E-Mailed
Jun 5, 2019
Suspension Letter Written
May 16, 2019
Preliminary/Voluntary Amendment - Entered
May 16, 2019
Teas Voluntary Amendment Received
Dec 6, 2018
Notification Of Non-Final Action E-Mailed
Dec 6, 2018
Non-Final Action E-Mailed
Dec 6, 2018
Non-Final Action Written
Nov 28, 2018
Assigned To Examiner
Aug 16, 2018
New Application Office Supplied Data Entered In Tram
Aug 13, 2018
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
